Rank | Gene Set | Z-score |
---|---|---|
1 | response to peptidoglycan (GO:0032494) | 5.67397320 |
2 | positive regulation of chemokine biosynthetic process (GO:0045080) | 5.32834790 |
3 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.16196284 |
4 | neutrophil activation involved in immune response (GO:0002283) | 5.14689564 |
5 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.10578276 |
6 | negative regulation of interleukin-12 production (GO:0032695) | 5.09970530 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.03769245 |
8 | modulation by symbiont of host defense response (GO:0052031) | 5.03769245 |
9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.03769245 |
10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.03769245 |
11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.03769245 |
12 | modulation by symbiont of host immune response (GO:0052553) | 5.03769245 |
13 | regulation of chemokine biosynthetic process (GO:0045073) | 5.03169992 |
14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.93788111 |
15 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.81554090 |
16 | leukocyte aggregation (GO:0070486) | 4.78411045 |
17 | positive regulation of heat generation (GO:0031652) | 4.78025965 |
18 | neutrophil mediated immunity (GO:0002446) | 4.75164691 |
19 | positive regulation of interferon-alpha production (GO:0032727) | 4.60486509 |
20 | regulation of vitamin metabolic process (GO:0030656) | 4.56775996 |
21 | regulation of fever generation (GO:0031620) | 4.55231628 |
22 | response to muramyl dipeptide (GO:0032495) | 4.50433985 |
23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.47343096 |
24 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.41988773 |
25 | regulation of interferon-alpha production (GO:0032647) | 4.35382070 |
26 | respiratory burst (GO:0045730) | 4.31351537 |
27 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.30666598 |
28 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.26209488 |
29 | immunoglobulin mediated immune response (GO:0016064) | 3.95405846 |
30 | macrophage activation involved in immune response (GO:0002281) | 3.94189009 |
31 | detection of other organism (GO:0098543) | 3.93265780 |
32 | regulation of histone phosphorylation (GO:0033127) | 3.91658835 |
33 | reactive oxygen species biosynthetic process (GO:1903409) | 3.82170422 |
34 | T-helper 1 type immune response (GO:0042088) | 3.81249561 |
35 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.80006878 |
36 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.78635770 |
37 | leukocyte mediated cytotoxicity (GO:0001909) | 3.78357198 |
38 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.70983258 |
39 | myeloid leukocyte mediated immunity (GO:0002444) | 3.70625120 |
40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.69046693 |
41 | granulocyte activation (GO:0036230) | 3.67908070 |
42 | negative regulation of cell killing (GO:0031342) | 3.62699608 |
43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.62699608 |
44 | cellular extravasation (GO:0045123) | 3.60069682 |
45 | regulation of heat generation (GO:0031650) | 3.59800838 |
46 | natural killer cell mediated immunity (GO:0002228) | 3.55859415 |
47 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.55859415 |
48 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.54178893 |
49 | detection of bacterium (GO:0016045) | 3.52074242 |
50 | superoxide anion generation (GO:0042554) | 3.50556371 |
51 | cytokine secretion (GO:0050663) | 3.50353769 |
52 | microglial cell activation (GO:0001774) | 3.49903786 |
53 | detection of external biotic stimulus (GO:0098581) | 3.49455257 |
54 | myeloid cell activation involved in immune response (GO:0002275) | 3.46846358 |
55 | neutrophil activation (GO:0042119) | 3.44728413 |
56 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.44205647 |
57 | regulation of growth of symbiont in host (GO:0044126) | 3.44205647 |
58 | negative regulation of growth of symbiont in host (GO:0044130) | 3.44205647 |
59 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.44205647 |
60 | defense response to protozoan (GO:0042832) | 3.41145137 |
61 | B cell mediated immunity (GO:0019724) | 3.40408463 |
62 | positive regulation of interferon-beta production (GO:0032728) | 3.38987986 |
63 | cellular response to interferon-beta (GO:0035458) | 3.38606622 |
64 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.37453422 |
65 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.37332582 |
66 | positive regulation of type 2 immune response (GO:0002830) | 3.36706314 |
67 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.35052996 |
68 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.33775257 |
69 | macrophage activation (GO:0042116) | 3.33015883 |
70 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.31015852 |
71 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.30071989 |
72 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.29845637 |
73 | response to host immune response (GO:0052572) | 3.29426950 |
74 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29426950 |
75 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.28930918 |
76 | positive regulation of antigen processing and presentation (GO:0002579) | 3.26197674 |
77 | regulation of antigen processing and presentation (GO:0002577) | 3.25895270 |
78 | myeloid dendritic cell activation (GO:0001773) | 3.24926576 |
79 | glycosphingolipid catabolic process (GO:0046479) | 3.24491870 |
80 | response to interferon-beta (GO:0035456) | 3.23863107 |
81 | oligosaccharide catabolic process (GO:0009313) | 3.23589323 |
82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22961521 |
83 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.22326607 |
84 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.20376882 |
85 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.19524817 |
86 | myeloid dendritic cell differentiation (GO:0043011) | 3.18861822 |
87 | regulation of mast cell degranulation (GO:0043304) | 3.18564161 |
88 | cellular response to zinc ion (GO:0071294) | 3.17791588 |
89 | detection of biotic stimulus (GO:0009595) | 3.17600421 |
90 | positive regulation of B cell differentiation (GO:0045579) | 3.16341340 |
91 | germinal center formation (GO:0002467) | 3.16058300 |
92 | T cell migration (GO:0072678) | 3.15506321 |
93 | regulation of leukocyte degranulation (GO:0043300) | 3.10933795 |
94 | pinocytosis (GO:0006907) | 3.10576985 |
95 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.10180090 |
96 | neutrophil chemotaxis (GO:0030593) | 3.08122086 |
97 | positive regulation of chemokine production (GO:0032722) | 3.06222446 |
98 | positive regulation of prostaglandin secretion (GO:0032308) | 3.05462583 |
99 | positive regulation of mast cell degranulation (GO:0043306) | 3.05115190 |
100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.05115190 |
101 | regulation of tolerance induction (GO:0002643) | 3.05062542 |
102 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.05010391 |
103 | response to host (GO:0075136) | 3.05010391 |
104 | response to host defenses (GO:0052200) | 3.05010391 |
105 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.04103755 |
106 | regulation of interleukin-12 production (GO:0032655) | 3.02132020 |
107 | response to protozoan (GO:0001562) | 3.01658354 |
108 | neutrophil migration (GO:1990266) | 3.01366913 |
109 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.01070682 |
110 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.00388318 |
111 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.00181563 |
112 | cellular response to virus (GO:0098586) | 2.99458147 |
113 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.98739695 |
114 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.98584496 |
115 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.98584496 |
116 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.98577925 |
117 | positive regulation of mast cell activation (GO:0033005) | 2.98376282 |
118 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.97182610 |
119 | negative regulation of interleukin-17 production (GO:0032700) | 2.96893304 |
120 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.96176363 |
121 | regulation of mast cell activation (GO:0033003) | 2.95684373 |
122 | cellular response to interferon-gamma (GO:0071346) | 2.95100265 |
123 | positive regulation of leukocyte degranulation (GO:0043302) | 2.94845012 |
124 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.94773188 |
125 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.94463395 |
126 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.94431945 |
127 | detection of molecule of bacterial origin (GO:0032490) | 2.93408770 |
128 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.93274794 |
129 | regulation of T cell tolerance induction (GO:0002664) | 2.93018429 |
130 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.92289927 |
131 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.92253525 |
132 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.92109554 |
133 | positive regulation of interleukin-2 production (GO:0032743) | 2.91761281 |
134 | type I interferon signaling pathway (GO:0060337) | 2.91555856 |
135 | cellular response to type I interferon (GO:0071357) | 2.91555856 |
136 | regulation of activation of Janus kinase activity (GO:0010533) | 2.91524385 |
137 | glycolipid catabolic process (GO:0019377) | 2.90995627 |
138 | regulation of prostaglandin secretion (GO:0032306) | 2.90234367 |
139 | response to type I interferon (GO:0034340) | 2.88693898 |
140 | positive regulation of interleukin-12 production (GO:0032735) | 2.88251622 |
141 | positive regulation of interleukin-6 production (GO:0032755) | 2.88081622 |
142 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.87562813 |
143 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.86644654 |
144 | negative regulation of T cell mediated immunity (GO:0002710) | 2.83066518 |
145 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.82116352 |
146 | regulation of interleukin-17 production (GO:0032660) | 2.80412682 |
147 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.79523552 |
148 | regulation of mononuclear cell migration (GO:0071675) | 2.79370065 |
149 | response to interferon-gamma (GO:0034341) | 2.76639809 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.38940312 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.49029978 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.73508043 |
4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.21069549 |
5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.18558101 |
6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.96675916 |
7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.93340621 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.82155450 |
9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.76405162 |
10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.65544126 |
11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.16004284 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.12094658 |
13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.01267975 |
14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.95200186 |
15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.92862498 |
16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.91009956 |
17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.71195965 |
18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.55204233 |
19 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.45113679 |
20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.44641967 |
21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44167465 |
22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.43018506 |
23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.42516683 |
24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.31433103 |
25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21070911 |
26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15892568 |
27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.01197608 |
28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.97804655 |
29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93870561 |
30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.92572272 |
31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.88793403 |
32 | MYB_26560356_Chip-Seq_TH2_Human | 1.88679854 |
33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.86998322 |
34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.86670425 |
35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80373101 |
36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78105423 |
37 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.76060399 |
38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73350108 |
39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.72221317 |
40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71425634 |
41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.70154544 |
42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.67511389 |
43 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.65096532 |
44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62429088 |
45 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.54869894 |
46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.54207014 |
47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52610924 |
48 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.51180472 |
49 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.49818404 |
50 | MAF_26560356_Chip-Seq_TH1_Human | 1.46404531 |
51 | MYB_26560356_Chip-Seq_TH1_Human | 1.43768967 |
52 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41753959 |
53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39006951 |
54 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38979001 |
55 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36483312 |
56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31416055 |
57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25153307 |
58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22298974 |
59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.20590629 |
60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16607806 |
61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15928114 |
62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15322482 |
63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.15207629 |
64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14695245 |
65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10687053 |
66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09916659 |
67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09907713 |
68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09862105 |
69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.06630426 |
70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03148264 |
71 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01212241 |
72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00113076 |
73 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.99484193 |
74 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98495862 |
75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97267572 |
76 | MYC_22102868_ChIP-Seq_BL_Human | 0.97158679 |
77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97134686 |
78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94358437 |
79 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93505534 |
80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91337744 |
81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88207930 |
82 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87916473 |
83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87902787 |
84 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87135747 |
85 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85194509 |
86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84397981 |
87 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83186242 |
88 | MAF_26560356_Chip-Seq_TH2_Human | 0.81488121 |
89 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.79994509 |
90 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79644375 |
91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.78982004 |
92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.75160411 |
93 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.73600594 |
94 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.72610584 |
95 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71770309 |
96 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71006915 |
97 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.69820462 |
98 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.69351874 |
99 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.67634359 |
100 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66529167 |
101 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.66356004 |
102 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.66239148 |
103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66133299 |
104 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.66089986 |
105 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.64589586 |
106 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.64415513 |
107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.61920170 |
108 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.59779833 |
109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.59234511 |
110 | P300_27268052_Chip-Seq_Bcells_Human | 0.59022144 |
111 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.58187490 |
112 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.57774068 |
113 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.57477721 |
114 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.57328090 |
115 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.57037103 |
116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.56441613 |
117 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.55580998 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009785_altered_susceptibility_to | 4.18865347 |
2 | MP0001835_abnormal_antigen_presentation | 4.13336920 |
3 | MP0003436_decreased_susceptibility_to | 3.73981743 |
4 | MP0002148_abnormal_hypersensitivity_rea | 3.60872537 |
5 | MP0002419_abnormal_innate_immunity | 3.41573230 |
6 | MP0005000_abnormal_immune_tolerance | 3.17411435 |
7 | MP0005025_abnormal_response_to | 3.13944225 |
8 | MP0003303_peritoneal_inflammation | 3.10550819 |
9 | MP0003724_increased_susceptibility_to | 2.85746107 |
10 | MP0006082_CNS_inflammation | 2.71442018 |
11 | MP0005464_abnormal_platelet_physiology | 2.64236417 |
12 | MP0002452_abnormal_antigen_presenting | 2.61187811 |
13 | MP0005058_abnormal_lysosome_morphology | 2.60098601 |
14 | MP0002723_abnormal_immune_serum | 2.49328763 |
15 | MP0000569_abnormal_digit_pigmentation | 2.48349238 |
16 | MP0002006_tumorigenesis | 2.37033261 |
17 | MP0001800_abnormal_humoral_immune | 2.35996819 |
18 | MP0001790_abnormal_immune_system | 2.31859300 |
19 | MP0005387_immune_system_phenotype | 2.31859300 |
20 | MP0001819_abnormal_immune_cell | 2.26125628 |
21 | MP0005174_abnormal_tail_pigmentation | 2.24537566 |
22 | MP0002420_abnormal_adaptive_immunity | 2.24120148 |
23 | MP0003172_abnormal_lysosome_physiology | 2.23461341 |
24 | MP0005671_abnormal_response_to | 2.18239011 |
25 | MP0000685_abnormal_immune_system | 2.14524806 |
26 | MP0005167_abnormal_blood-brain_barrier | 2.12300901 |
27 | MP0009764_decreased_sensitivity_to | 2.10997625 |
28 | MP0000858_altered_metastatic_potential | 2.06005674 |
29 | MP0009278_abnormal_bone_marrow | 2.01226222 |
30 | MP0004510_myositis | 1.95474977 |
31 | MP0001845_abnormal_inflammatory_respons | 1.94927033 |
32 | MP0004947_skin_inflammation | 1.94352710 |
33 | MP0003448_altered_tumor_morphology | 1.92265342 |
34 | MP0003300_gastrointestinal_ulcer | 1.86933055 |
35 | MP0003183_abnormal_peptide_metabolism | 1.85914049 |
36 | MP0001533_abnormal_skeleton_physiology | 1.82313007 |
37 | MP0001853_heart_inflammation | 1.82066551 |
38 | MP0005397_hematopoietic_system_phenotyp | 1.78325032 |
39 | MP0001545_abnormal_hematopoietic_system | 1.78325032 |
40 | MP0002405_respiratory_system_inflammati | 1.77978794 |
41 | MP0008469_abnormal_protein_level | 1.77320320 |
42 | MP0010155_abnormal_intestine_physiology | 1.77098021 |
43 | MP0000343_altered_response_to | 1.76545787 |
44 | MP0009333_abnormal_splenocyte_physiolog | 1.71367199 |
45 | MP0000716_abnormal_immune_system | 1.65648386 |
46 | MP0002398_abnormal_bone_marrow | 1.62480432 |
47 | MP0002139_abnormal_hepatobiliary_system | 1.54549552 |
48 | MP0008004_abnormal_stomach_pH | 1.47228075 |
49 | MP0003806_abnormal_nucleotide_metabolis | 1.43934630 |
50 | MP0003191_abnormal_cellular_cholesterol | 1.40773094 |
51 | MP0002429_abnormal_blood_cell | 1.38278718 |
52 | MP0000689_abnormal_spleen_morphology | 1.37814384 |
53 | MP0003075_altered_response_to | 1.36373987 |
54 | MP0005451_abnormal_body_composition | 1.35934124 |
55 | MP0002722_abnormal_immune_system | 1.33737884 |
56 | MP0002998_abnormal_bone_remodeling | 1.31362352 |
57 | MP0000015_abnormal_ear_pigmentation | 1.29744006 |
58 | MP0009840_abnormal_foam_cell | 1.28173798 |
59 | MP0005166_decreased_susceptibility_to | 1.27537235 |
60 | MP0000490_abnormal_crypts_of | 1.24070399 |
61 | MP0003186_abnormal_redox_activity | 1.23061758 |
62 | MP0002396_abnormal_hematopoietic_system | 1.21972923 |
63 | MP0004808_abnormal_hematopoietic_stem | 1.18328803 |
64 | MP0009763_increased_sensitivity_to | 1.14576880 |
65 | MP0005310_abnormal_salivary_gland | 1.12622215 |
66 | MP0003828_pulmonary_edema | 1.03343522 |
67 | MP0003690_abnormal_glial_cell | 1.02505018 |
68 | MP0006054_spinal_hemorrhage | 1.02085374 |
69 | MP0001851_eye_inflammation | 1.01275017 |
70 | MP0002166_altered_tumor_susceptibility | 1.00978582 |
71 | MP0000604_amyloidosis | 1.00795629 |
72 | MP0003656_abnormal_erythrocyte_physiolo | 0.98075762 |
73 | MP0005164_abnormal_response_to | 0.97846532 |
74 | MP0000371_diluted_coat_color | 0.89786208 |
75 | MP0000249_abnormal_blood_vessel | 0.88344837 |
76 | MP0002332_abnormal_exercise_endurance | 0.88179516 |
77 | MP0000465_gastrointestinal_hemorrhage | 0.87838144 |
78 | MP0003763_abnormal_thymus_physiology | 0.87251846 |
79 | MP0010307_abnormal_tumor_latency | 0.85102622 |
80 | MP0003195_calcinosis | 0.83424892 |
81 | MP0002138_abnormal_hepatobiliary_system | 0.81264627 |
82 | MP0004782_abnormal_surfactant_physiolog | 0.80897456 |
83 | MP0001873_stomach_inflammation | 0.80827617 |
84 | MP0005390_skeleton_phenotype | 0.79481028 |
85 | MP0005075_abnormal_melanosome_morpholog | 0.78333502 |
86 | MP0009765_abnormal_xenobiotic_induced | 0.74909645 |
87 | MP0003566_abnormal_cell_adhesion | 0.74711808 |
88 | MP0010352_gastrointestinal_tract_polyps | 0.73871632 |
89 | MP0003866_abnormal_defecation | 0.73843844 |
90 | MP0000703_abnormal_thymus_morphology | 0.73621813 |
91 | MP0002933_joint_inflammation | 0.73075484 |
92 | MP0008260_abnormal_autophagy | 0.70219263 |
93 | MP0002136_abnormal_kidney_physiology | 0.69781649 |
94 | MP0005076_abnormal_cell_differentiation | 0.68596905 |
95 | MP0002095_abnormal_skin_pigmentation | 0.68128401 |
96 | MP0005165_increased_susceptibility_to | 0.66578409 |
97 | MP0005319_abnormal_enzyme/_coenzyme | 0.66364127 |
98 | MP0003329_amyloid_beta_deposits | 0.64043750 |
99 | MP0003091_abnormal_cell_migration | 0.62479061 |
100 | MP0003453_abnormal_keratinocyte_physiol | 0.61033112 |
101 | MP0008873_increased_physiological_sensi | 0.60869336 |
102 | MP0008874_decreased_physiological_sensi | 0.60704720 |
103 | MP0001663_abnormal_digestive_system | 0.60232748 |
104 | MP0004883_abnormal_blood_vessel | 0.59947524 |
105 | MP0002254_reproductive_system_inflammat | 0.59119635 |
106 | MP0003795_abnormal_bone_structure | 0.58977975 |
107 | MP0002277_abnormal_respiratory_mucosa | 0.58822745 |
108 | MP0005647_abnormal_sex_gland | 0.58275026 |
109 | MP0002877_abnormal_melanocyte_morpholog | 0.56578445 |
110 | MP0002019_abnormal_tumor_incidence | 0.55961828 |
111 | MP0000920_abnormal_myelination | 0.55755125 |
112 | MP0000609_abnormal_liver_physiology | 0.53852691 |
113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.50305902 |
114 | MP0005535_abnormal_body_temperature | 0.49575694 |
115 | MP0000598_abnormal_liver_morphology | 0.48910564 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 7.17785835 |
2 | Eczematoid dermatitis (HP:0000976) | 6.94623351 |
3 | Recurrent bacterial skin infections (HP:0005406) | 6.59267467 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.84321205 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.63898102 |
6 | Mediastinal lymphadenopathy (HP:0100721) | 5.22126722 |
7 | Stomatitis (HP:0010280) | 4.80830137 |
8 | Abnormality of macrophages (HP:0004311) | 4.74155764 |
9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.61690260 |
10 | Increased cerebral lipofuscin (HP:0011813) | 4.58754770 |
11 | Myositis (HP:0100614) | 4.49120076 |
12 | Vacuolated lymphocytes (HP:0001922) | 4.30256533 |
13 | Recurrent skin infections (HP:0001581) | 4.13086122 |
14 | Orchitis (HP:0100796) | 3.95673678 |
15 | Gingivitis (HP:0000230) | 3.85283342 |
16 | Recurrent fungal infections (HP:0002841) | 3.79530253 |
17 | Obstructive lung disease (HP:0006536) | 3.76339942 |
18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.76339942 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 3.67492400 |
20 | Retrobulbar optic neuritis (HP:0100654) | 3.63697043 |
21 | Optic neuritis (HP:0100653) | 3.63697043 |
22 | Vasculitis (HP:0002633) | 3.59032377 |
23 | Periodontitis (HP:0000704) | 3.49927398 |
24 | Loss of speech (HP:0002371) | 3.49885595 |
25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.48707754 |
26 | Interstitial pulmonary disease (HP:0006530) | 3.34088012 |
27 | Petechiae (HP:0000967) | 3.32214182 |
28 | Prostate neoplasm (HP:0100787) | 3.31183948 |
29 | Cellulitis (HP:0100658) | 3.26723945 |
30 | Basal ganglia calcification (HP:0002135) | 3.18915427 |
31 | Neoplasm of head and neck (HP:0012288) | 3.15919747 |
32 | Esophageal neoplasm (HP:0100751) | 3.15919747 |
33 | Recurrent viral infections (HP:0004429) | 3.10831599 |
34 | Systemic lupus erythematosus (HP:0002725) | 3.07599832 |
35 | Thrombocytosis (HP:0001894) | 2.97430358 |
36 | Abnormality of the prostate (HP:0008775) | 2.95503779 |
37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.88122767 |
38 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.88122767 |
39 | Urticaria (HP:0001025) | 2.85626596 |
40 | Leukocytosis (HP:0001974) | 2.84039095 |
41 | Encephalitis (HP:0002383) | 2.83992498 |
42 | Meningitis (HP:0001287) | 2.79675031 |
43 | Axonal loss (HP:0003447) | 2.76246438 |
44 | Gastrointestinal infarctions (HP:0005244) | 2.76041136 |
45 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.75914260 |
46 | Disinhibition (HP:0000734) | 2.75788400 |
47 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.74938454 |
48 | T lymphocytopenia (HP:0005403) | 2.73016130 |
49 | Mutism (HP:0002300) | 2.72525339 |
50 | Gingival bleeding (HP:0000225) | 2.69859778 |
51 | Pulmonary infiltrates (HP:0002113) | 2.69207938 |
52 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.67853311 |
53 | Myocardial infarction (HP:0001658) | 2.64446561 |
54 | Osteomyelitis (HP:0002754) | 2.63621457 |
55 | Premature loss of primary teeth (HP:0006323) | 2.62577117 |
56 | Agnosia (HP:0010524) | 2.58579577 |
57 | Abnormality of T cell number (HP:0011839) | 2.58548710 |
58 | Pustule (HP:0200039) | 2.51109351 |
59 | Joint hemorrhage (HP:0005261) | 2.50804527 |
60 | Epistaxis (HP:0000421) | 2.49180000 |
61 | Hypergammaglobulinemia (HP:0010702) | 2.47363005 |
62 | Recurrent pneumonia (HP:0006532) | 2.44352309 |
63 | Amyloidosis (HP:0011034) | 2.41809524 |
64 | Hemoptysis (HP:0002105) | 2.41226081 |
65 | Arterial thrombosis (HP:0004420) | 2.39710615 |
66 | Abnormality of glycolipid metabolism (HP:0010969) | 2.37406606 |
67 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.37406606 |
68 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.37406606 |
69 | Pulmonary embolism (HP:0002204) | 2.33054456 |
70 | Tetraparesis (HP:0002273) | 2.31652531 |
71 | Inflammation of the large intestine (HP:0002037) | 2.28699929 |
72 | Panhypogammaglobulinemia (HP:0003139) | 2.26616489 |
73 | Dysostosis multiplex (HP:0000943) | 2.26365012 |
74 | Bone pain (HP:0002653) | 2.24614987 |
75 | Increased serum ferritin (HP:0003281) | 2.24540178 |
76 | Eosinophilia (HP:0001880) | 2.23428873 |
77 | Keratoconjunctivitis sicca (HP:0001097) | 2.22667526 |
78 | Parakeratosis (HP:0001036) | 2.19845510 |
79 | Albinism (HP:0001022) | 2.19514557 |
80 | Autoimmune hemolytic anemia (HP:0001890) | 2.19462738 |
81 | Amaurosis fugax (HP:0100576) | 2.18068560 |
82 | Gastrointestinal inflammation (HP:0004386) | 2.14276909 |
83 | Recurrent lower respiratory tract infections (HP:0002783) | 2.13377861 |
84 | Abnormality of the pleura (HP:0002103) | 2.08349113 |
85 | Neurofibrillary tangles (HP:0002185) | 2.08280066 |
86 | Prolonged bleeding time (HP:0003010) | 2.06846030 |
87 | Abnormality of the periventricular white matter (HP:0002518) | 2.06423591 |
88 | Hepatosplenomegaly (HP:0001433) | 2.05607288 |
89 | Diminished motivation (HP:0000745) | 2.04478820 |
90 | Apathy (HP:0000741) | 2.02481051 |
91 | Thick nail (HP:0001805) | 2.02355246 |
92 | Abnormality of T cells (HP:0002843) | 2.02282660 |
93 | Granulocytopenia (HP:0001913) | 2.01650668 |
94 | Abnormality of iron homeostasis (HP:0011031) | 2.01631521 |
95 | Agammaglobulinemia (HP:0004432) | 2.01064741 |
96 | Hematochezia (HP:0002573) | 2.00033495 |
97 | Glomerulopathy (HP:0100820) | 1.99819940 |
98 | Vertigo (HP:0002321) | 1.99812492 |
99 | Polyneuropathy (HP:0001271) | 1.99614847 |
100 | Keratoconjunctivitis (HP:0001096) | 1.99513234 |
101 | Increased IgE level (HP:0003212) | 1.99238878 |
102 | Chest pain (HP:0100749) | 1.95474272 |
103 | Inappropriate behavior (HP:0000719) | 1.94116076 |
104 | Skin ulcer (HP:0200042) | 1.93657756 |
105 | Increased IgM level (HP:0003496) | 1.93138493 |
106 | Chronic otitis media (HP:0000389) | 1.92799933 |
107 | Progressive neurologic deterioration (HP:0002344) | 1.91724031 |
108 | Neuronal loss in central nervous system (HP:0002529) | 1.90162972 |
109 | Episodic fever (HP:0001954) | 1.90099951 |
110 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89910369 |
111 | Mucopolysacchariduria (HP:0008155) | 1.89910369 |
112 | Restrictive lung disease (HP:0002091) | 1.89348978 |
113 | Gangrene (HP:0100758) | 1.88414239 |
114 | Poikiloderma (HP:0001029) | 1.87399461 |
115 | Spontaneous hematomas (HP:0007420) | 1.85880693 |
116 | IgM deficiency (HP:0002850) | 1.85690372 |
117 | Purpura (HP:0000979) | 1.85239885 |
118 | Progressive visual loss (HP:0000529) | 1.83679802 |
119 | Porencephaly (HP:0002132) | 1.83310373 |
120 | Abnormal platelet function (HP:0011869) | 1.83213759 |
121 | Impaired platelet aggregation (HP:0003540) | 1.83213759 |
122 | Bone cyst (HP:0012062) | 1.82838912 |
123 | Nausea (HP:0002018) | 1.81777520 |
124 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.78750448 |
125 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.78750448 |
126 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.78750448 |
127 | Colitis (HP:0002583) | 1.78672849 |
128 | Abnormality of eosinophils (HP:0001879) | 1.77821237 |
129 | Pathologic fracture (HP:0002756) | 1.77687385 |
130 | Glomerulonephritis (HP:0000099) | 1.77305301 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BLK | 4.56757531 |
2 | MAP3K14 | 4.45830514 |
3 | RIPK4 | 3.77823889 |
4 | TXK | 3.54081668 |
5 | IRAK3 | 3.44302179 |
6 | TBK1 | 3.34457711 |
7 | MAP4K1 | 3.33665526 |
8 | IRAK4 | 3.33085893 |
9 | IKBKE | 2.62804630 |
10 | KIT | 2.52582183 |
11 | GRK7 | 2.44226129 |
12 | JAK3 | 2.29213157 |
13 | IKBKB | 2.16534564 |
14 | EPHB1 | 2.14606315 |
15 | ZAP70 | 2.13308435 |
16 | PRPF4B | 2.04523790 |
17 | ERN1 | 2.03285795 |
18 | PIM2 | 1.98851799 |
19 | TYK2 | 1.96299030 |
20 | TAOK3 | 1.84118372 |
21 | BTK | 1.78795761 |
22 | TEC | 1.76374290 |
23 | SYK | 1.64515574 |
24 | CHUK | 1.63857682 |
25 | PBK | 1.48456313 |
26 | HCK | 1.33400459 |
27 | EPHA3 | 1.32808003 |
28 | JAK1 | 1.29840834 |
29 | IRAK2 | 1.29549132 |
30 | LYN | 1.23963650 |
31 | FES | 1.23308811 |
32 | MAP2K3 | 1.22928713 |
33 | PIM1 | 1.20997056 |
34 | ABL2 | 1.19889572 |
35 | TAOK2 | 1.17357206 |
36 | MAP3K3 | 1.16887399 |
37 | NME2 | 1.13520017 |
38 | LCK | 1.10635509 |
39 | CSF1R | 1.10399049 |
40 | JAK2 | 1.08068098 |
41 | EIF2AK2 | 1.04664029 |
42 | DDR2 | 1.04540625 |
43 | MATK | 1.02184605 |
44 | CSK | 0.98686744 |
45 | ADRBK2 | 0.97306739 |
46 | MST4 | 0.91075042 |
47 | MOS | 0.90934460 |
48 | FLT3 | 0.90628159 |
49 | MAP3K12 | 0.89141143 |
50 | TNK2 | 0.88830158 |
51 | RIPK1 | 0.87669104 |
52 | DAPK2 | 0.87626621 |
53 | FGFR3 | 0.87375243 |
54 | BMX | 0.86622817 |
55 | NEK9 | 0.85003200 |
56 | CDC42BPA | 0.82819952 |
57 | PIK3CG | 0.81174206 |
58 | MAP3K13 | 0.80378585 |
59 | TAOK1 | 0.79709997 |
60 | STK4 | 0.76636776 |
61 | PRKCD | 0.75617550 |
62 | MST1R | 0.75073878 |
63 | ERBB4 | 0.71793969 |
64 | CAMKK2 | 0.69274896 |
65 | CLK1 | 0.67840574 |
66 | MAP3K5 | 0.66469633 |
67 | TGFBR2 | 0.66377639 |
68 | BMPR2 | 0.65227900 |
69 | STK10 | 0.63924161 |
70 | PDPK1 | 0.63889264 |
71 | RPS6KA4 | 0.62759516 |
72 | ABL1 | 0.62594812 |
73 | CDK6 | 0.59961977 |
74 | LRRK2 | 0.58962627 |
75 | IRAK1 | 0.57885609 |
76 | TGFBR1 | 0.57209928 |
77 | MAPK7 | 0.56356646 |
78 | TRPM7 | 0.54926586 |
79 | EIF2AK3 | 0.54794264 |
80 | ITK | 0.54416029 |
81 | MAP2K6 | 0.53901413 |
82 | FGFR4 | 0.53648084 |
83 | MAP3K10 | 0.49500748 |
84 | YES1 | 0.48939306 |
85 | EGFR | 0.48161189 |
86 | SIK3 | 0.47570690 |
87 | PRKG2 | 0.47248494 |
88 | MAPKAPK2 | 0.44393021 |
89 | FGR | 0.44340945 |
90 | RPS6KA6 | 0.44139092 |
91 | PAK4 | 0.43409967 |
92 | BMPR1B | 0.43114931 |
93 | NLK | 0.42849437 |
94 | SCYL2 | 0.40941306 |
95 | MAP3K6 | 0.40170582 |
96 | MARK3 | 0.39934333 |
97 | CDK4 | 0.37922409 |
98 | MUSK | 0.37455430 |
99 | TTN | 0.36160922 |
100 | CDK8 | 0.35516736 |
101 | RPS6KA2 | 0.34549972 |
102 | MAPK4 | 0.33765835 |
103 | SIK2 | 0.33249225 |
104 | MAPK12 | 0.33024730 |
105 | CAMK1D | 0.32905062 |
106 | PDK1 | 0.32094533 |
107 | PAK2 | 0.31789217 |
108 | MAP3K1 | 0.30401068 |
109 | KSR2 | 0.30030713 |
110 | ALK | 0.29859928 |
111 | MAP3K11 | 0.29210558 |
112 | MAP4K2 | 0.29009359 |
113 | DAPK3 | 0.28864380 |
114 | PRKCQ | 0.28538854 |
115 | TESK2 | 0.28365324 |
116 | MAP3K2 | 0.27671556 |
117 | CDK19 | 0.25850155 |
118 | FYN | 0.25473130 |
119 | PTK6 | 0.25448220 |
120 | GRK6 | 0.25345677 |
121 | ACVR1B | 0.24961093 |
122 | ATR | 0.24650551 |
123 | HIPK2 | 0.24548667 |
124 | MAPK3 | 0.24247257 |
125 | RPS6KL1 | 0.23482973 |
126 | RPS6KC1 | 0.23482973 |
127 | SGK3 | 0.21416585 |
128 | IGF1R | 0.21209080 |
129 | MARK2 | 0.19319216 |
130 | MAP2K4 | 0.19286271 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.94058812 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.72652620 |
3 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 3.26702533 |
4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.96054373 |
5 | Legionellosis_Homo sapiens_hsa05134 | 2.77701603 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.77165110 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.65007525 |
8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.60730541 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.56324698 |
10 | Pertussis_Homo sapiens_hsa05133 | 2.47370531 |
11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.42395551 |
12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.42054715 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.39248769 |
14 | Malaria_Homo sapiens_hsa05144 | 2.35775019 |
15 | Tuberculosis_Homo sapiens_hsa05152 | 2.33502329 |
16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.30404692 |
17 | Measles_Homo sapiens_hsa05162 | 2.19732255 |
18 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.01482833 |
19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.88645355 |
20 | Allograft rejection_Homo sapiens_hsa05330 | 1.86215410 |
21 | Salmonella infection_Homo sapiens_hsa05132 | 1.84346180 |
22 | Asthma_Homo sapiens_hsa05310 | 1.80424685 |
23 | Influenza A_Homo sapiens_hsa05164 | 1.76817782 |
24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75836111 |
25 | Phagosome_Homo sapiens_hsa04145 | 1.67392853 |
26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.63889997 |
27 | Lysosome_Homo sapiens_hsa04142 | 1.63529803 |
28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54504521 |
29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.53980168 |
30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.50753395 |
31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.44450460 |
32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35373177 |
33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33577221 |
34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31508130 |
35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29568103 |
36 | Shigellosis_Homo sapiens_hsa05131 | 1.26060233 |
37 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24571847 |
38 | Apoptosis_Homo sapiens_hsa04210 | 1.18009346 |
39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16091779 |
40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09476563 |
41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04468828 |
42 | Hepatitis B_Homo sapiens_hsa05161 | 1.02197562 |
43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01179395 |
44 | Hepatitis C_Homo sapiens_hsa05160 | 1.00056646 |
45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98685460 |
46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97879964 |
47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.96871333 |
48 | Amoebiasis_Homo sapiens_hsa05146 | 0.91237154 |
49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87999841 |
50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82295422 |
51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78239622 |
52 | Prion diseases_Homo sapiens_hsa05020 | 0.77981965 |
53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72852379 |
54 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69244037 |
55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67202054 |
56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66791278 |
57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62475319 |
58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62319807 |
59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62218196 |
60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62206458 |
61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61163852 |
62 | Platelet activation_Homo sapiens_hsa04611 | 0.58386821 |
63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55488075 |
64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54263651 |
65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54167895 |
66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53063601 |
67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52538252 |
68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50349246 |
69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50121752 |
70 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47090981 |
71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45533536 |
72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45110781 |
73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45059801 |
74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44386225 |
75 | Bladder cancer_Homo sapiens_hsa05219 | 0.41916961 |
76 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40317865 |
77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38699455 |
78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37680662 |
79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37571188 |
80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37157725 |
81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36911661 |
82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.36139095 |
83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34044544 |
84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33598670 |
85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31849604 |
86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31309199 |
87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30838971 |
88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28991070 |
89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28084321 |
90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27703952 |
91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.26729061 |
92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25593161 |
93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25254707 |
94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23786370 |
95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23329268 |
96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23237477 |
97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22428869 |
98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.21958243 |
99 | Insulin resistance_Homo sapiens_hsa04931 | 0.20941220 |
100 | Endocytosis_Homo sapiens_hsa04144 | 0.20223854 |
101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20187576 |
102 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.20155738 |
103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18792145 |
104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18402083 |
105 | DNA replication_Homo sapiens_hsa03030 | 0.18345803 |
106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.18146346 |
107 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.17992951 |
108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.17911594 |
109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17688596 |
110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.17206040 |
111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14290628 |
112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.13873205 |
113 | Mineral absorption_Homo sapiens_hsa04978 | 0.13496190 |
114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.13080693 |
115 | Histidine metabolism_Homo sapiens_hsa00340 | 0.12743233 |
116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12517201 |
117 | Ribosome_Homo sapiens_hsa03010 | 0.11342855 |
118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.11102318 |